Tuberculosis vaccines for cattle: The way forward

Expert Review of Vaccines

Volumn 9, Issue 10, 2010, Pages 1121-1124

  Buddle, Bryce M ^a  

^a AGRESEARCH GRASSLANDS   (New Zealand)

Author keywords

bovine tuberculosis; cattle; differential diagnosis; Mycobacterium bovis; vaccines

Indexed keywords

BCG VACCINE;

BACTERIAL STRAIN; CATTLE; DRUG ACTIVITY; DRUG MECHANISM; EDITORIAL; ENDEMIC DISEASE; HUMAN; IMMUNITY; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; VACCINATION;

ANIMALS; BCG VACCINE; CATTLE; MYCOBACTERIUM BOVIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, BOVINE; VACCINATION;

EID: 77957954442     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.112     Document Type: Editorial

References (35)

1. Steele JH. Regional and country status report. In: Mycobacterium Bovis Infection in Animals and Humans. Thoen CO, Steele JH (Eds). Iowa Press, IA, USA, 169-172 (1995).
2. Cousins DV. Mycobacterium bovis infection and control in domestic livestock. Rev. Sci. Tech. 20, 71-85 (2001).
3. Vordermeier HM, Chambers MA, Buddle BM, Pollock JM, Hewinson RG. Progress in the development of vaccines to control tuberculosis in cattle. Vet. J. 171, 229-244 (2006).
4. Buddle BM, Collins DM. Development of tuberculosis vaccines for cattle. CAB Rev. 73, 1-8 (2007).
5. Buddle BM, Wedlock DN, Parlane NA, Corner LA, de Lisle GW, Skinner MA. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect. Immun. 71, 6411-6419 (2003).
6. Hope JC, Thom ML, Villarreal-Ramos B, Vordermeier HM, Hewinson RG, Howard CJ. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin. Exp. Immunol. 139, 48-56 (2005).
7. Parida SK, Kaufmann SHE. Novel tuberculosis vaccines on the horizon. Curr. Opin. Immunol. 22, 374-384 (2010).
8. Skinner MA, Buddle BM, Wedlock D et al. A DNA prime - Mycobacterium bovis BCG boost vaccination strategy in cattle induces protection against bovine tuberculosis. Infect. Immun. 71, 4901-4907 (2003).
9. Maue AC, Waters WR, Palmer MV et al. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis. Vaccine 25, 4735-4746 (2007).
10. Wedlock DN, Denis M, Skinner MA et al. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to vaccination with BCG alone. Infect. Immun. 73, 3540-3546 (2005).
11. Wedlock DN, Denis M, Painter GF et al. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG and a mycobacterial protein vaccine-adjuvant combination, but not after coadministration of adjuvant alone. Clin. Vaccine Immunol. 15, 765-772 (2008).
12. Vordermeier HM, Villaraeal-Ramos B, Cockle PJ et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77, 3364-3373 (2009).
13. Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20, 1126-1133 (2002).
14. Murphy D, Corner LAL, Gormley E. Adverse reactions to Mycobacterium bovis bacilli Calmette Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species. Tuberculosis 88, 344-357 (2008).
15. Francis J. Bovine Tuberculosis, Including a Contrast with Human Tuberculosis. Staples Press, London, UK (1947).
16. Berggren SA. Field experiment with BCG vaccine in Malawi. Br. Vet. J. 137, 88-94 (1981).
17. Skinner MA, Wedlock DN, Buddle BM. Vaccination of animals against Mycobacterium bovis. Rev. Sci. Tech. 20, 112-132 (2001).
18. Lopez-Valencia G, Renteria-Evangelista T, de Jesús Williams J, Licea-Navarro A, De la Mora-Valle A, Medina-Basulto G. Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis. Res. Vet. Sci. 88(1), 44-49 (2009).
19. Ameni G, Aseffa A, Engers H et al. High prevalence and increased severity of pathology of bovine tuberculosis in Holsteins compared to zebu breeds under field cattle husbandry in central Ethiopia. Clin. Vaccine Immunol. 14, 1356-1361 (2007).
20. Hope JC, Thom ML, Villarreal-Ramos B, Vordermeier HM, Hewinson RG, Howard CJ. Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle. Clin. Exp. Immunol. 141, 432-439 (2005).
21. Moore SE, Collinson AC, Tamba N Gom P, Aspinall R, Prentice AM. Early immunological development and mortality from infectious disease in later life. Proc. Nutr. Soc. 65, 311-318 (2006).
22. Flynn RJ, Mulcahy G, Welsh M et al. Co-infection of cattle with Fasciola hepatica and Mycobacterium bovis - immunological consequences. Transbound. Emerg. Dis. 56, 269-274 (2009).
23. Schiller I, Waters WR, Vordermeier HM et al. Optimization of a whole-blood g interferon assay for detection of Mycobacterium bovis-infected cattle. Clin. Vaccine Immunol. 16, 1196-1202 (2009).
24. Buddle BM, Parlane NA, Keen DL et al. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin. Diagn. Lab. Immunol. 6, 1-5 (1999).
25. Vordermeier HM, Whelan A, Cockle PJ, Farrant L, Palmer N, Hewinson RG. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 8, 571-578 (2001).
26. Cockle PJ, Gordon SV, Lalvani A, Buddle BM, Hewinson RG, Vordermeier HM. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect. Immun. 70, 6996-7003 (2002).
27. Sidders B, Pirson C, Hogarth PJ et al. Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential antigen for the Mycobacterium tuberculosis complex. Infect. Immun. 76, 3932-3939 (2008).
28. Sopp P, Coad M, Hewinson G et al. Development of a simple, sensitive, rapid test which discriminates BCG vaccinated from Mycobacterium bovis-infected cattle. Vaccine 26, 5470-5476 (2008).
29. Whelan C, Whelan AO, Shuralev E et al. Performance of the Enferplex TB assay with cattle in Great Britain and assessment of its suitability as a test to distinguish infected and vaccinated animals. Clin. Vaccine Immunol. 17, 813-817 (2010).
30. Whelan AO, Clifford D, Upadhyay B et al. Development of a skin-test for bovine tuberculosis. J. Clin. Microbiol. 48(9), 3176-3181 (2010).
31. Aagaard C, Dietrich J, Doherty M, Andersen P. TB vaccines: current status and future perspectives. Immunol. Cell Biol. 87, 279-286 (2009).
32. Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG at birth in Hong Kong. Int. J. Tuberc. Lung Dis. 5, 717-723 (2001).
33. Brandt L, Feino Cunha J, Weinreich Olsen A et al. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70, 672-678 (2002).
34. Fine PE, Sterne JA, Ponnighaus JM, Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344, 1245-1249. (1994).
35. Orme IM, Collins FM. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell. Immunol. 84, 113-120 (1984).